Skip to main content
Fig. 2 | Journal of Experimental & Clinical Cancer Research

Fig. 2

From: Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer

Fig. 2

CASC9 promotes the proliferation but does not affect the apoptosis of BCCs. a and b The proliferation changes of BCCs were determined using CCK-8 assay in vitro. c and d The proliferation changes of BCCs were determined using Edu assay in vitro. e Tumours collected from mice are shown. f Tumor weight of shRNA-NC group was greater than that in the shRNA-CASC9 group. g Tumor growth of shRNA-NC was faster than that in the shRNA-CASC9 group. h The expression of Ki67 was determined using Immunohistochemistry. i and j The changes in bladder cancer cell apoptosis were determined using flow cytometry. The data are shown as the mean ± SD. *P < 0.05; **P < 0.01

Back to article page